RecruitingPhase 3NCT06623422A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)Sponsor: Merck Sharp & Dohme LLCBuffalo, NY · East Syracuse, NY · New York, NY · +51 more sites
RecruitingNot applicableNCT07403539Speech Learning and Speech Production in Parkinson's DiseaseSponsor: State University of New York at BuffaloBuffalo, NY
RecruitingPhase 2NCT07002034RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical IllnessesSponsor: Reunion Neuroscience IncBuffalo, NY · New York, NY · +30 more sites
RecruitingPhase 3NCT06944522A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's DiseaseSponsor: BlueRock TherapeuticsBuffalo, NY · New York, NY · +31 more sites